{"transactions":[{"id":967145,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:34:59.000Z","date":"2025-12-15","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.42,"value":1050.0,"ownership":{"direct":true},"balance_after":216932,"source":{"system":"sec-edgar","filing":"0001213900-25-122429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025122429/ownership.xml","form_type":"4"}},{"id":967144,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:34:59.000Z","date":"2025-12-15","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.41,"value":1025.0,"ownership":{"direct":true},"balance_after":214432,"source":{"system":"sec-edgar","filing":"0001213900-25-122429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025122429/ownership.xml","form_type":"4"}},{"id":991087,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-21T23:35:50.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.365,"value":365.0,"ownership":{"direct":true},"balance_after":211932,"source":{"system":"sec-edgar","filing":"0001213900-25-113743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025113743/ownership.xml","form_type":"4"}},{"id":991086,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-21T23:35:50.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.37,"value":370.0,"ownership":{"direct":true},"balance_after":210932,"source":{"system":"sec-edgar","filing":"0001213900-25-113743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025113743/ownership.xml","form_type":"4"}},{"id":992323,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-20T21:00:32.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":0.405,"value":1822.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":209932,"source":{"system":"sec-edgar","filing":"0001213900-25-113104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025113104/ownership.xml","form_type":"4"}},{"id":992322,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-20T21:00:32.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":0.4033,"value":3024.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":205432,"source":{"system":"sec-edgar","filing":"0001213900-25-113104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025113104/ownership.xml","form_type":"4"}},{"id":1131581,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-28T20:30:42.000Z","date":"2025-05-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.4329,"value":4329.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $0.42 to $0.45, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":197932,"source":{"system":"sec-edgar","filing":"0001213900-25-048304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025048304/ownership.xml","form_type":"4"}},{"id":1133533,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":43536,"kind":"person","name":"Linsley Wayne","position":1,"cik":"0001809972","reported_name":"Linsley Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-05-27T23:03:42.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant."}],"balance_after":53425,"derivative":{"exercise_price":0.429,"exercise_date":"2026-05-23","expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-047915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809972/000121390025047915/ownership.xml","form_type":"4"}},{"id":1133000,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":79207,"kind":"person","name":"Munoz Kevin","position":1,"cik":"0001847763","reported_name":"Munoz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-05-27T23:03:16.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant."}],"balance_after":53425,"derivative":{"exercise_price":0.429,"exercise_date":"2026-05-23","expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-047914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025047914/ownership.xml","form_type":"4"}},{"id":1132999,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2025-05-27T23:02:27.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant."}],"balance_after":387932,"derivative":{"exercise_price":0.429,"exercise_date":"2026-05-23","expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-25-047912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025047912/ownership.xml","form_type":"4"}},{"id":1132998,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":43443,"kind":"person","name":"Pavell Jeff","position":1,"cik":"0001840601","reported_name":"Pavell Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-05-27T23:00:58.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":0.429,"exercise_date":"2026-05-23","expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-047910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025047910/ownership.xml","form_type":"4"}},{"id":1133381,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":79214,"kind":"person","name":"Ryweck Daniel E.","position":1,"cik":"0001652799","reported_name":"Ryweck Daniel E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2025-05-27T19:02:50.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant."}],"balance_after":55000,"derivative":{"exercise_price":0.429,"exercise_date":"2026-05-23","expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-047913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652799/000121390025047913/ownership.xml","form_type":"4"}},{"id":1330556,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-12-16T22:00:06.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.8387,"value":2096.75,"ownership":{"direct":true},"balance_after":187932,"source":{"system":"sec-edgar","filing":"0001213900-24-109363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024109363/ownership.xml","form_type":"4"}},{"id":1353838,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-11-22T21:16:10.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.9,"value":2250.0,"ownership":{"direct":true},"balance_after":185432,"source":{"system":"sec-edgar","filing":"0001213900-24-101610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024101610/ownership.xml","form_type":"4"}},{"id":1353837,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-11-22T21:16:10.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.95,"value":2375.0,"ownership":{"direct":true},"balance_after":182932,"source":{"system":"sec-edgar","filing":"0001213900-24-101610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024101610/ownership.xml","form_type":"4"}},{"id":1480266,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-13T17:19:05.000Z","date":"2024-06-12","kind":"purchase","planned":false,"acquired":true,"shares":4438,"price":1.11,"value":4926.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.12. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":180432,"source":{"system":"sec-edgar","filing":"0001213900-24-052354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024052354/ownership.xml","form_type":"4"}},{"id":1480265,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-13T17:19:05.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":562,"price":1.08,"value":606.96,"ownership":{"direct":true},"balance_after":175994,"source":{"system":"sec-edgar","filing":"0001213900-24-052354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024052354/ownership.xml","form_type":"4"}},{"id":1545297,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-08T20:00:40.000Z","date":"2024-04-05","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":2.03,"value":812.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.05. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":175432,"source":{"system":"sec-edgar","filing":"0001213900-24-031159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024031159/ownership.xml","form_type":"4"}},{"id":1545296,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-08T20:00:40.000Z","date":"2024-04-04","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":1.96,"value":1176.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.96 to $1.97. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":175032,"source":{"system":"sec-edgar","filing":"0001213900-24-031159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024031159/ownership.xml","form_type":"4"}},{"id":1555948,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-01T22:15:06.000Z","date":"2024-04-01","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":1.91,"value":2101.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $1.93. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":174432,"source":{"system":"sec-edgar","filing":"0001213900-24-028973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024028973/ownership.xml","form_type":"4"}},{"id":1555947,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-01T22:15:06.000Z","date":"2024-03-28","kind":"purchase","planned":false,"acquired":true,"shares":3408,"price":1.94,"value":6611.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.91 to $1.95. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":173332,"source":{"system":"sec-edgar","filing":"0001213900-24-028973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390024028973/ownership.xml","form_type":"4"}},{"id":1701945,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-21T21:13:38.000Z","date":"2023-12-20","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":1.61,"value":322.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.63. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":169924,"source":{"system":"sec-edgar","filing":"0001213900-23-097689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023097689/ownership.xml","form_type":"4"}},{"id":1701944,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-21T21:13:38.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":1.63,"value":815.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.65. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":169724,"source":{"system":"sec-edgar","filing":"0001213900-23-097689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023097689/ownership.xml","form_type":"4"}},{"id":1706758,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-19T00:44:46.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":1.52,"value":1368.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.52. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":169224,"source":{"system":"sec-edgar","filing":"0001213900-23-096606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023096606/ownership.xml","form_type":"4"}},{"id":1706757,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-19T00:44:46.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":1.5,"value":300.0,"ownership":{"direct":true},"balance_after":168324,"source":{"system":"sec-edgar","filing":"0001213900-23-096606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023096606/ownership.xml","form_type":"4"}},{"id":1718903,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-07T23:13:51.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":324,"price":1.36,"value":440.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.34 to $1.40. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":168124,"source":{"system":"sec-edgar","filing":"0001213900-23-094145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023094145/ownership.xml","form_type":"4"}},{"id":1718902,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-07T23:13:51.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":76,"price":1.34,"value":101.84,"ownership":{"direct":true},"balance_after":167800,"source":{"system":"sec-edgar","filing":"0001213900-23-094145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023094145/ownership.xml","form_type":"4"}},{"id":1718901,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-07T23:13:51.000Z","date":"2023-12-05","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":1.39,"value":834.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.40. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":167724,"source":{"system":"sec-edgar","filing":"0001213900-23-094145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023094145/ownership.xml","form_type":"4"}},{"id":1726560,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-01T02:10:20.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.53,"value":1530.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.52 to $1.55. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":167124,"source":{"system":"sec-edgar","filing":"0001213900-23-091665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023091665/ownership.xml","form_type":"4"}},{"id":1726559,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-01T02:10:20.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.57,"value":1570.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.56 to $1.57. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":166124,"source":{"system":"sec-edgar","filing":"0001213900-23-091665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023091665/ownership.xml","form_type":"4"}},{"id":1729376,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-27T22:13:33.000Z","date":"2023-11-27","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":1.78,"value":445.0,"ownership":{"direct":true},"balance_after":165124,"source":{"system":"sec-edgar","filing":"0001213900-23-090270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023090270/ownership.xml","form_type":"4"}},{"id":1729375,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-27T22:13:33.000Z","date":"2023-11-22","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":1.68,"value":672.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.70. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":164874,"source":{"system":"sec-edgar","filing":"0001213900-23-090270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023090270/ownership.xml","form_type":"4"}},{"id":1730827,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-22T21:01:10.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":1.56,"value":468.0,"ownership":{"direct":true},"balance_after":164474,"source":{"system":"sec-edgar","filing":"0001213900-23-089570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023089570/ownership.xml","form_type":"4"}},{"id":1730826,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-22T21:01:10.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":4050,"price":1.6,"value":6480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.57 to $1.65. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":164174,"source":{"system":"sec-edgar","filing":"0001213900-23-089570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023089570/ownership.xml","form_type":"4"}},{"id":1734257,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-21T00:51:06.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":1.54,"value":2772.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.60. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":160124,"source":{"system":"sec-edgar","filing":"0001213900-23-088890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023088890/ownership.xml","form_type":"4"}},{"id":1734256,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-21T00:51:06.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":1.33,"value":1463.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.46. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":158324,"source":{"system":"sec-edgar","filing":"0001213900-23-088890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023088890/ownership.xml","form_type":"4"}},{"id":1876519,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":79214,"kind":"person","name":"Ryweck Daniel E.","position":1,"cik":"0001652799","reported_name":"Ryweck Daniel E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-26T16:17:23.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.1264,"value":2126.4,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-23-043531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652799/000121390023043531/ownership.xml","form_type":"4"}},{"id":1886545,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-05-18T20:15:14.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.107,"value":1053.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at $2.104 and $2.109. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":157724,"source":{"system":"sec-edgar","filing":"0001213900-23-041179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023041179/ownership.xml","form_type":"4"}},{"id":1886544,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-05-18T20:15:14.000Z","date":"2023-05-17","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.06,"value":5150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.000 to $2.0899. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":157224,"source":{"system":"sec-edgar","filing":"0001213900-23-041179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023041179/ownership.xml","form_type":"4"}},{"id":2079502,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-12-21T00:07:59.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":130,"price":2.72,"value":353.6,"ownership":{"direct":true},"balance_after":154854,"source":{"system":"sec-edgar","filing":"0001213900-22-081513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022081513/ownership.xml","form_type":"4"}},{"id":2079501,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-12-21T00:07:59.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":200,"price":2.6815,"value":536.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.713. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":154724,"source":{"system":"sec-edgar","filing":"0001213900-22-081513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022081513/ownership.xml","form_type":"4"}},{"id":2084858,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-12-15T21:15:51.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":263,"price":3.1699,"value":833.6837,"ownership":{"direct":true},"balance_after":154524,"source":{"system":"sec-edgar","filing":"0001213900-22-080102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022080102/ownership.xml","form_type":"4"}},{"id":2084857,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-12-15T21:15:51.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":487,"price":3.0676,"value":1493.9212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.992 to $3.20. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":154261,"source":{"system":"sec-edgar","filing":"0001213900-22-080102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022080102/ownership.xml","form_type":"4"}},{"id":2225016,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Common Stock","published_at":"2022-06-21T12:05:06.000Z","date":"2022-06-17","kind":"purchase","acquired":true,"shares":13080,"price":0.1147,"value":1500.276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1302 to $0.11. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7724643,"source":{"system":"sec-edgar","filing":"0001213900-22-033752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022033752/ownership.xml","form_type":"4"}},{"id":2444337,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":43536,"kind":"person","name":"Linsley Wayne","position":1,"cik":"0001809972","reported_name":"Linsley Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-01-05T23:18:55.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":171233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This Form 4/A deletes the second Non-Qualified Stock Option for 171,233 shares erroneously reported in the original Form 4 filed on January 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Vests over the course of one year from grant with 100% vesting a year from the date of grant."}],"balance_after":171233,"derivative":{"exercise_price":0.146,"exercise_date":"2021-12-29","expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":171233},"source":{"system":"sec-edgar","filing":"0001213900-22-000777","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809972/000121390022000777/ownership.xml","form_type":"4/A","original_submission_date":"2022-01-03"}},{"id":2454492,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":43536,"kind":"person","name":"Linsley Wayne","position":1,"cik":"0001809972","reported_name":"Linsley Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-01-04T02:55:43.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":171233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Vests over the course of one year from grant with 100% vesting a year from the date of grant."}],"balance_after":342466,"derivative":{"exercise_price":0.146,"exercise_date":"2021-12-29","expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":171233},"source":{"system":"sec-edgar","filing":"0001213900-22-000364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809972/000121390022000364/ownership.xml","form_type":"4"}},{"id":2454491,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":43536,"kind":"person","name":"Linsley Wayne","position":1,"cik":"0001809972","reported_name":"Linsley Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-01-04T02:55:43.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":171233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Vests over the course of one year from grant with 100% vesting a year from the date of grant."}],"balance_after":171233,"derivative":{"exercise_price":0.146,"exercise_date":"2021-12-29","expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":171233},"source":{"system":"sec-edgar","filing":"0001213900-22-000364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809972/000121390022000364/ownership.xml","form_type":"4"}},{"id":2453744,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":79207,"kind":"person","name":"Munoz Kevin","position":1,"cik":"0001847763","reported_name":"Munoz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-01-04T02:55:14.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":171233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Vests over the course of one year from grant with 100% vesting a year from the date of grant."}],"balance_after":171233,"derivative":{"exercise_price":0.146,"exercise_date":"2021-12-29","expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":171233},"source":{"system":"sec-edgar","filing":"0001213900-22-000363","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022000363/ownership.xml","form_type":"4"}},{"id":2471277,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-15T18:31:09.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":17500,"price":0.1377,"value":2409.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.131 to $0.1455. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7711563,"source":{"system":"sec-edgar","filing":"0001213900-21-065395","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021065395/ownership.xml","form_type":"4"}},{"id":2471276,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-15T18:31:09.000Z","date":"2021-12-10","kind":"purchase","acquired":true,"shares":5000,"price":0.1554,"value":777.0,"ownership":{"direct":true},"balance_after":7694063,"source":{"system":"sec-edgar","filing":"0001213900-21-065395","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021065395/ownership.xml","form_type":"4"}},{"id":2709969,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Common Stock","published_at":"2021-05-17T11:33:20.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":7630949,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued to the Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, by and between the Issuer and the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on April 30, 2020, which erroneously included the Reporting Person's stock options in Column 5 of Table I."}],"balance_after":7689063,"source":{"system":"sec-edgar","filing":"0001213900-21-026677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026677/ownership.xml","form_type":"4/A","original_submission_date":"2020-04-30"}},{"id":2709968,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T11:31:56.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":0.0001,"exercise_date":"2019-10-15","expiration_date":"2024-10-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-026675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026675/ownership.xml","form_type":"4"}},{"id":2709967,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T11:31:56.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The options were granted on April 15, 2019 and vested in full on July 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on April 15, 2019 and vested in full on July 15, 2019."}],"balance_after":100000,"derivative":{"exercise_price":0.0001,"exercise_date":"2019-07-15","expiration_date":"2024-07-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-026675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026675/ownership.xml","form_type":"4"}},{"id":2709966,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T11:31:56.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019."}],"balance_after":100000,"derivative":{"exercise_price":0.0001,"exercise_date":"2019-04-15","expiration_date":"2024-04-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-026675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026675/ownership.xml","form_type":"4"}},{"id":2709965,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Common Stock","published_at":"2021-05-17T11:31:56.000Z","date":"2019-10-22","kind":"purchase","acquired":true,"shares":200,"price":0.45,"value":90.0,"ownership":{"direct":true},"balance_after":58114,"source":{"system":"sec-edgar","filing":"0001213900-21-026675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026675/ownership.xml","form_type":"4"}},{"id":2709964,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Common Stock","published_at":"2021-05-17T11:31:56.000Z","date":"2019-10-15","kind":"purchase","acquired":true,"shares":200,"price":0.38,"value":76.0,"ownership":{"direct":true},"balance_after":57914,"source":{"system":"sec-edgar","filing":"0001213900-21-026675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026675/ownership.xml","form_type":"4"}},{"id":2709963,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and President"}}],"security":"Common Stock","published_at":"2021-05-17T11:31:56.000Z","date":"2019-06-17","kind":"purchase","acquired":true,"shares":57714,"price":0.002,"value":115.428,"ownership":{"direct":true},"balance_after":57714,"source":{"system":"sec-edgar","filing":"0001213900-21-026675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390021026675/ownership.xml","form_type":"4"}},{"id":3166276,"issuer":{"id":8320,"kind":"organization","name":"Silo Pharma, Inc."},"owners":[{"id":71413,"kind":"person","name":"Weisblum Eric","position":1,"cik":"0001569077","reported_name":"Weisblum Eric","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2020-05-01T00:42:56.000Z","date":"2020-04-17","kind":"grant","acquired":true,"shares":7630949,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued to Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, between the Issuer and Reporting Person."}],"balance_after":7988663,"source":{"system":"sec-edgar","filing":"0001213900-20-010688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390020010688/ownership.xml","form_type":"4"}}]}